You are here

Home » CERID Bibliography

CERID Bibliography

Export 120 results:
Author Title Type [ Year(Asc)]
Filters: Author is Gale, Michael  [Clear All Filters]
2013
Wollish AC, Ferris MT, Blevins LK, Loo Y-M, Gale M, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology. 2013 ;435(2):269-80.
Ma DY, Suthar MS, Kasahara S, Gale M, Clark EA. CD22 is required for protection against West Nile virus Infection. J Virol. 2013 ;87(6):3361-75.
Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013 ;19(4):458-64.
Errett JS, Suthar MS, McMillan A, Diamond MS, Gale M. The Essential, Nonredundant Roles of RIG-I and MDA5 in Detecting and Controlling West Nile Virus Infection. J Virol. 2013 ;87(21):11416-11425.
Stone AEL, Giugliano S, Schnell G, Cheng L, Leahy KF, Golden-Mason L, Gale M, Rosen HR. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLoS Pathog. 2013 ;9(4):e1003316.
Wilkins C, Woodward J, Lau DT-Y, Barnes A, Joyce M, McFarlane N, McKeating JA, D Tyrrell L, Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2013 ;57(2):461-9.
Negash AA, Ramos HJ, Crochet N, T Y Lau D, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, et al. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013 ;9(4):e1003330.
Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M, Verma S. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J Virol. 2013 ;87(7):3655-67.
Mateo R, Nagamine CM, Spagnolo J, Méndez E, Rahe M, Gale M, Yuan J, Kirkegaard K. Inhibition of cellular autophagy deranges dengue virion maturation. J Virol. 2013 ;87(3):1312-21.
Lau DT-Y, Negash A, Chen J, Crochet N, Sinha M, Zhang Y, Guedj J, Holder S, Saito T, Lemon SM, et al. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology. 2013 ;144(2):402-413.e12.
Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013 ;9(1):e1003118.
Lazear HM, Pinto AK, Ramos HJ, Vick SC, Shrestha B, Suthar MS, Gale M, Diamond MS. Pattern Recognition Receptor MDA5 Modulates CD8+ T Cell-Dependent Clearance of West Nile Virus from the Central Nervous System. J Virol. 2013 ;87(21):11401-11415.
Horner SM, Gale M. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med. 2013 ;19(7):879-88.
Ermler ME, Yerukhim E, Schriewer J, Schattgen S, Traylor Z, Wespiser AR, Caffrey DR, Chen ZJ, King CH, Gale M, et al. RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. J Virol. 2013 ;87(9):4846-60.
Li J, Ding SC, Cho H, Chung BC, Gale M, Chanda SK, Diamond MS. A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. MBio. 2013 ;4(3):e00385-13.
Wilkins C, Gale M. Sterol-izing innate immunity. Immunity. 2013 ;38(1):3-5.
Ireton RC, Gale M. Systems biology analyses to define host responses to HCV infection and therapy. Curr Top Microbiol Immunol. 2013 ;363:143-67.
Suthar MS, Brassil MM, Blahnik G, McMillan A, Ramos HJ, Proll SC, Belisle SE, Katze MG, Gale M. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog. 2013 ;9(2):e1003168.
Rustagi A, Doehle BP, McElrath JM, Gale M. Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion. Methods. 2013 ;59(2):225-32.
Suthar MS, Diamond MS, Gale M. West Nile virus infection and immunity. Nat Rev Microbiol. 2013 ;11(2):115-28.
2012
Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M, Virgin HW, Klein RS, Sen GC, Diamond MS. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012 ;8(5):e1002698.
Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M, Barber GN, Stetson DB. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012 ;36(1):120-31.
Diamond MS, Gale M. Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol. 2012 ;33(10):522-30.
Horner SM, Park HSoo, Gale M. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol. 2012 ;86(6):3112-20.
Patel MR, Loo Y-M, Horner SM, Gale M, Malik HS. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol. 2012 ;10(3):e1001282.

Pages